Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Meperidine as the Single Sedative Agent for Patients Expected to Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy.

NCT01948921 is registered in ClinicalTrials.gov with Dalin Tzu Chi General Hospital as lead sponsor.

NCT NCT01948921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01948921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Meperidine as the Single Sedative Agent for Patients Expected to Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy.
Lead sponsor
Dalin Tzu Chi General Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2013
Completion date
March 31, 2017
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients undergoing diagnostic egd